Alternate sources and substitutes for therapeutic blood components

R. A. Kahn, R. W. Allen, J. Baldassare

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

With the rapid advancement of technology, blood substitutes and alternate sources of therapeutic blood components are likely to become available, although not for a number of years. Within five to eight years, at least some plasma derivatives probably will be replaced by alternate sources using recombinant DNA technology; substitutes for RBCs and platelets will be much more difficult to develop. Availability of these products will have far-reaching effects on our health care system and it is probably not too soon to anticipate the effects and plan for the consequences.

Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalBlood
Volume66
Issue number1
StatePublished - 1 Dec 1985

Fingerprint

Blood Substitutes
Genetic engineering
Platelets
Health care
Blood
Availability
Technology
Derivatives
Plasmas
Recombinant DNA
Blood Platelets
Delivery of Health Care
Therapeutics

Cite this

Kahn, R. A. ; Allen, R. W. ; Baldassare, J. / Alternate sources and substitutes for therapeutic blood components. In: Blood. 1985 ; Vol. 66, No. 1. pp. 1-12.
@article{1da69ab33000494594419afbf314550e,
title = "Alternate sources and substitutes for therapeutic blood components",
abstract = "With the rapid advancement of technology, blood substitutes and alternate sources of therapeutic blood components are likely to become available, although not for a number of years. Within five to eight years, at least some plasma derivatives probably will be replaced by alternate sources using recombinant DNA technology; substitutes for RBCs and platelets will be much more difficult to develop. Availability of these products will have far-reaching effects on our health care system and it is probably not too soon to anticipate the effects and plan for the consequences.",
author = "Kahn, {R. A.} and Allen, {R. W.} and J. Baldassare",
year = "1985",
month = "12",
day = "1",
language = "English",
volume = "66",
pages = "1--12",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

Kahn, RA, Allen, RW & Baldassare, J 1985, 'Alternate sources and substitutes for therapeutic blood components', Blood, vol. 66, no. 1, pp. 1-12.

Alternate sources and substitutes for therapeutic blood components. / Kahn, R. A.; Allen, R. W.; Baldassare, J.

In: Blood, Vol. 66, No. 1, 01.12.1985, p. 1-12.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Alternate sources and substitutes for therapeutic blood components

AU - Kahn, R. A.

AU - Allen, R. W.

AU - Baldassare, J.

PY - 1985/12/1

Y1 - 1985/12/1

N2 - With the rapid advancement of technology, blood substitutes and alternate sources of therapeutic blood components are likely to become available, although not for a number of years. Within five to eight years, at least some plasma derivatives probably will be replaced by alternate sources using recombinant DNA technology; substitutes for RBCs and platelets will be much more difficult to develop. Availability of these products will have far-reaching effects on our health care system and it is probably not too soon to anticipate the effects and plan for the consequences.

AB - With the rapid advancement of technology, blood substitutes and alternate sources of therapeutic blood components are likely to become available, although not for a number of years. Within five to eight years, at least some plasma derivatives probably will be replaced by alternate sources using recombinant DNA technology; substitutes for RBCs and platelets will be much more difficult to develop. Availability of these products will have far-reaching effects on our health care system and it is probably not too soon to anticipate the effects and plan for the consequences.

UR - http://www.scopus.com/inward/record.url?scp=0022262106&partnerID=8YFLogxK

M3 - Review article

C2 - 2860936

AN - SCOPUS:0022262106

VL - 66

SP - 1

EP - 12

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -